This pharmacy benefit management company's relatively small size can be a big asset.
One company Motley Fool health0care bureau chief Brenton Flynn followed at the J.P. Morgan conference yesterday was pharmacy benefit manager Catamaran (CTRX.DL). In the following video, he discusses some takeaways from the company's presentation, including a few moves the company will be making to drive further shareholder value this year.
The relevant video segment can be found between 7:53 and 9:31.
Brenton Flynn has no position in any stocks mentioned. The Motley Fool recommends and owns owns shares of Catamaran and Express Scripts. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
